Anchor Capital Advisors LLC Sells 389 Shares of Transcat, Inc. (NASDAQ:TRNS)

Anchor Capital Advisors LLC decreased its holdings in Transcat, Inc. (NASDAQ:TRNS) by 6.2% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 5,909 shares of the scientific and technical instruments company’s stock after selling 389 shares during the period. Anchor Capital Advisors LLC’s holdings in Transcat were worth $646,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in TRNS. Comerica Bank bought a new position in shares of Transcat during the 3rd quarter worth approximately $5,221,000. Vanguard Group Inc. raised its stake in Transcat by 13.3% during the third quarter. Vanguard Group Inc. now owns 425,378 shares of the scientific and technical instruments company’s stock worth $41,674,000 after acquiring an additional 49,828 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in shares of Transcat by 196.7% during the third quarter. Charles Schwab Investment Management Inc. now owns 59,482 shares of the scientific and technical instruments company’s stock valued at $5,827,000 after acquiring an additional 39,432 shares during the period. Kornitzer Capital Management Inc. KS boosted its stake in shares of Transcat by 103.2% in the 3rd quarter. Kornitzer Capital Management Inc. KS now owns 63,200 shares of the scientific and technical instruments company’s stock valued at $6,192,000 after purchasing an additional 32,100 shares in the last quarter. Finally, EAM Investors LLC bought a new stake in shares of Transcat in the 3rd quarter worth about $2,962,000. Institutional investors own 98.34% of the company’s stock.

Transcat Stock Performance

Transcat stock opened at $107.37 on Wednesday. Transcat, Inc. has a 1 year low of $76.05 and a 1 year high of $116.19. The company’s 50-day moving average is $108.77 and its two-hundred day moving average is $102.86. The company has a current ratio of 3.37, a quick ratio of 2.81 and a debt-to-equity ratio of 0.01. The company has a market cap of $948.08 million, a PE ratio of 82.59 and a beta of 0.59.

Transcat (NASDAQ:TRNS) last released its earnings results on Monday, January 29th. The scientific and technical instruments company reported $0.38 EPS for the quarter, topping analysts’ consensus estimates of $0.35 by $0.03. The firm had revenue of $65.17 million during the quarter, compared to analyst estimates of $63.36 million. Transcat had a net margin of 4.16% and a return on equity of 9.32%. Equities analysts anticipate that Transcat, Inc. will post 1.34 earnings per share for the current year.

Wall Street Analysts Forecast Growth

TRNS has been the subject of several analyst reports. HC Wainwright reissued a “buy” rating and set a $124.00 price target on shares of Transcat in a report on Tuesday, April 16th. TheStreet raised Transcat from a “c+” rating to a “b” rating in a report on Wednesday, January 31st. Finally, Oppenheimer reissued an “outperform” rating and issued a $125.00 price objective (up previously from $120.00) on shares of Transcat in a research note on Thursday, April 18th.

Insider Activity at Transcat

In related news, CEO Lee D. Rudow sold 5,000 shares of Transcat stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $111.30, for a total transaction of $556,500.00. Following the transaction, the chief executive officer now owns 108,478 shares of the company’s stock, valued at approximately $12,073,601.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, CEO Lee D. Rudow sold 5,000 shares of the company’s stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $111.30, for a total value of $556,500.00. Following the completion of the sale, the chief executive officer now owns 108,478 shares in the company, valued at approximately $12,073,601.40. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Charles P. Hadeed sold 700 shares of the firm’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $113.00, for a total value of $79,100.00. Following the sale, the director now directly owns 22,678 shares in the company, valued at approximately $2,562,614. The disclosure for this sale can be found here. Over the last quarter, insiders sold 8,073 shares of company stock worth $900,023. 4.20% of the stock is owned by insiders.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.